Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

BlackRock Portfolio Management Crosses 10% in Amerisafe

BlackRock Portfolio Management LLC filed an amended Schedule 13G with the SEC on November 4, 2026, disclosing a beneficial ownership stake of 10.1% in Amerisafe Inc as of October 31, 2026.

Manish Choudhary | 04 November 2026

Fannie Mae 29th NPL Sale: TRF Loan Acquisition Wins 1,179-Loan Pool

Fannie Mae (OTCQB:FNMA) announced on November 4, 2026, the results of its twenty-ninth non-performing loan sale transaction, with TRF Loan Acquisition, LP named as the winning bidder for a pool of 1,179 loans.

Vinay Lochav | 04 November 2026

ADC Therapeutics ZYNLONTA LOTIS-7 Data at ASH 2026

ADC Therapeutics SA filed a Form 8-K on November 4, 2026, disclosing new and updated clinical trial data for ZYNLONTA ahead of the 68th American Society of Hematology Annual Meeting, along with preliminary financial estimates for the period ended September 30, 2026.

Nitish Kishor | 04 November 2026

Ron Clayton Joins Thunder Mountain Gold Board Oct 1

Thunder Mountain Gold, Inc. filed a Form 8-K on November 4, 2026, disclosing the appointment of Ron Clayton as a director of the company, effective October 1, 2026, along with a grant of stock options as compensation for his service.

Anjali Anand | 04 November 2026

McGrath RentCorp Issues $75M 6.53% Series H Senior Notes

McGrath RentCorp filed a Form 8-K on November 4, 2026, disclosing that it entered into a First Amendment to its Second Amended and Restated Note Purchase and Private Shelf Agreement and issued $75 million in 6.53% Series H Senior Notes on November 2, 2026.

Aakashdeep | 04 November 2026

BML Investment Partners Discloses 6.7% Stake in LENZ Therapeutics

BML Investment Partners, L.P. filed a Schedule 13G with the SEC on November 4, 2026, disclosing beneficial ownership of 2,110,727 shares of LENZ Therapeutics, Inc. common stock, representing 6.7% of the class, as of a triggering event dated November 2, 2026.

Nitish Kishor | 04 November 2026

Expedia Group Declares $0.48 Dividend, Reports Q3 2026 Results

Expedia Group, Inc. filed a Form 8-K with the SEC on November 4, 2026, announcing its financial results for the quarter ended September 30, 2026 and declaring a quarterly cash dividend of $0.48 per share.

Aditi Sarkar | 04 November 2026

Teva's General Counsel Bergwerk Files to Sell 26,260 Shares

Dov Bergwerk, Senior Vice President, General Counsel, and Corporate Secretary of Teva Pharmaceutical Industries Ltd, filed a Form 144 notice of proposed sale of 26,260 ordinary shares on November 4, 2026, through a stock option exercise and sale transaction on the NYSE.

Shwetambri Chauhan | 04 November 2026

Niki Invest ApS Share Tender Not Completed in Cadeler Offer

Cadeler A/S filed a Form 6-K on 4 November 2026 disclosing an amendment to a previously announced PDMR transaction, reporting that a tendering of 87,410 shares by Niki Invest ApS in Cadeler plc's voluntary share exchange offer was not completed.

Aakashdeep | 04 November 2026

Alderman Exercises 4,378 FCN Options at $40.36

Paul Linton Alderman, Chief Strategy/Transformation Officer at FTI Consulting, Inc., filed a Form 4 on November 4, 2026, disclosing a stock option exercise and same-day sale of 4,378 shares of common stock on November 3, 2026.

Anjali Anand | 04 November 2026
Support

Hi! How can we help you today?

Loading…